Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
PIK3R2 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 7.21E4 | Evidence | O | ||||
PIK3R2 | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 5.72E4 | Evidence | O | ||||
PIK3R2 | INSR | INSR: Insulin receptor precursor | 5.39E4 | Evidence | |||||
PIK3R2 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 268.0 | Evidence | O | ||||
PIK3R2 | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 246.0 | Evidence | |||||
PIK3R2 | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 185.0 | Evidence | |||||
PIK3R2 | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 178.0 | Evidence | |||||
PIK3R2 | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 178.0 | Evidence | |||||
PIK3R2 | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 178.0 | Evidence | |||||
PIK3R2 | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 158.0 | Evidence | |||||
PIK3R2 | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 149.0 | Evidence | |||||
PIK3R2 | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 135.0 | Evidence | |||||
PIK3R2 | KIT | KIT: Mast/stem cell growth factor receptor precursor | 132.0 | Evidence | O | ||||
PIK3R2 | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 121.0 | Evidence | |||||
PIK3R2 | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 121.0 | Evidence | |||||
PIK3R2 | LYN | LYN: Tyrosine-protein kinase Lyn | 108.0 | Evidence | |||||
PIK3R2 | JAK1 | 108.0 | Evidence | ||||||
PIK3R2 | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 106.0 | Evidence | |||||
PIK3R2 | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 106.0 | Evidence | |||||
PIK3R2 | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 72.10 | Evidence | |||||
PIK3R2 | SYK | SYK: Tyrosine-protein kinase SYK | 71.10 | Evidence | |||||
PIK3R2 | CSK | CSK: Tyrosine-protein kinase CSK | 71.10 | Evidence | |||||
PIK3R2 | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 70.50 | Evidence | |||||
PIK3R2 | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 70.10 | Evidence | |||||
PIK3R2 | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 66.50 | Evidence | |||||
PIK3R2 | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 63.20 | Evidence | |||||
PIK3R2 | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 62.10 | Evidence | O | ||||
PIK3R2 | GRK1 | GRK1, RHOK: Rhodopsin kinase precursor | 43.60 | Evidence | |||||
PIK3R2 | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 33.90 | Evidence | |||||
PIK3R2 | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 33.90 | Evidence | |||||
PIK3R2 | GAB1 | GAB1: GRB2-associated-binding protein 1 | 28.20 | Evidence | |||||
PIK3R2 | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 26.40 | Evidence | |||||
PIK3R2 | APS | SH2B2, APS: SH2B adapter protein 2 | 25.3 | Evidence | |||||
PIK3R2 | CNKSR2 | CNKSR2, CNK2, KIAA0902, KSR2: Connector enhancer of kinase suppressor of ras 2 | 25.3 | Evidence | |||||
PIK3R2 | DAB2 | DAB2, DOC2: Disabled homolog 2 | 25.3 | Evidence | |||||
PIK3R2 | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 22.60 | Evidence | |||||
PIK3R2 | GRAP2 | GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 | 22.60 | Evidence | |||||
PIK3R2 | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 22.30 | Evidence | |||||
PIK3R2 | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 22.30 | Evidence | |||||
PIK3R2 | CRKL | CRKL: Crk-like protein | 22.20 | Evidence | O | ||||
PIK3R2 | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 20.50 | Evidence | O | ||||
PIK3R2 | NEK6 | NEK6: Serine/threonine-protein kinase Nek6 | 20.50 | Evidence | |||||
PIK3R2 | SH3KBP1 | SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 | 20.50 | Evidence | |||||
PIK3R2 | STAT3 | 20.50 | Evidence | ||||||
PIK3R2 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 20.00 | Evidence | |||||
PIK3R2 | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 20.00 | Evidence | |||||
PIK3R2 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 20.00 | Evidence | |||||
PIK3R2 | CTTN | CTTN, EMS1: Src substrate cortactin | 17.30 | Evidence | |||||
PIK3R2 | NCK2 | NCK2: Cytoplasmic protein NCK2 | 16.00 | Evidence | |||||
PIK3R2 | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 15.00 | Evidence | |||||
PIK3R2 | LNK | SH2B3, LNK: SH2B adapter protein 3 | 15.00 | Evidence | |||||
PIK3R2 | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 13.20 | Evidence | |||||
PIK3R2 | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 13.20 | Evidence | |||||
PIK3R2 | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 13.2 | Evidence | |||||
PIK3R2 | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 12.10 | Evidence | |||||
PIK3R2 | S100A16 | S100A16, AAG13: Protein S100-A16 | 11.90 | Evidence | |||||
PIK3R2 | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 11.80 | Evidence | |||||
PIK3R2 | WASPIP | N/A | 11.80 | Evidence | |||||
PIK3R2 | GRB10 | N/A | 11.70 | Evidence | |||||
PIK3R2 | ITGB3 | ITGB3, GP3A: Integrin beta-3 precursor | 11.60 | Evidence | |||||
PIK3R2 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 11.60 | Evidence | |||||
PIK3R2 | SYNGAP1 | SYNGAP1, KIAA1938: Ras GTPase-activating protein SynGAP | 10.50 | Evidence | |||||
PIK3R2 | MDGA1 | MDGA1, MAMDC3: MAM domain-containing glycosylphosphatidylinositol anchor protein | 10.10 | Evidence | |||||
PIK3R2 | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 10.00 | Evidence | |||||
PIK3R2 | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 10.00 | Evidence | |||||
PIK3R2 | PTPRJ | PTPRJ, DEP1: Receptor-type tyrosine-protein phosphatase eta precursor | 9.32 | Evidence | |||||
PIK3R2 | DOK1 | DOK1: Docking protein 1 | 9.0 | Evidence | |||||
PIK3R2 | VAV1 | VAV1, VAV: Proto-oncogene vav | 9.0 | Evidence | |||||
PIK3R2 | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 9.0 | Evidence | |||||
PIK3R2 | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 8.92 | Evidence | |||||
PIK3R2 | SOS1 | SOS1: Son of sevenless homolog 1 | 8.90 | Evidence | |||||
PIK3R2 | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 8.86 | Evidence | |||||
PIK3R2 | CD2AP | CD2AP: CD2-associated protein | 7.99 | Evidence | |||||
PIK3R2 | EPOR | EPOR: Erythropoietin receptor precursor | 7.40 | Evidence | |||||
PIK3R2 | MSN | MSN: Moesin | 7.14 | Evidence | |||||
PIK3R2 | PTPRG | PTPRG, PTPG: Receptor-type tyrosine-protein phosphatase gamma precursor | 6.76 | Evidence | |||||
PIK3R2 | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 6.62 | Evidence | |||||
PIK3R2 | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 6.62 | Evidence | |||||
PIK3R2 | CDC25A | CDC25A: M-phase inducer phosphatase 1 | 6.50 | Evidence | |||||
PIK3R2 | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 6.39 | Evidence | |||||
PIK3R2 | C9 | C9: Complement component C9 precursor [Contains: Complement component C9a; Compl | 6.37 | Evidence | |||||
PIK3R2 | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 6.17 | Evidence | |||||
PIK3R2 | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 5.88 | Evidence | |||||
PIK3R2 | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 5.04 | Evidence | O | ||||
PIK3R2 | SNX12 | N/A | 5.02 | Evidence | |||||
PIK3R2 | KIR2DL3 | KIR2DL3, CD158B2, KIRCL23, NKAT2: Killer cell immunoglobulin-like receptor 2DL3 | 4.80 | Evidence | |||||
PIK3R2 | MADCAM1 | MADCAM1: Mucosal addressin cell adhesion molecule 1 precursor | 4.80 | Evidence | |||||
PIK3R2 | MGMT | MGMT: Methylated-DNA--protein-cysteine methyltransferase | 4.77 | Evidence | |||||
PIK3R2 | GRB14 | GRB14: Growth factor receptor-bound protein 14 | 4.56 | Evidence | |||||
PIK3R2 | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 4.45 | Evidence | |||||
PIK3R2 | GRB7 | GRB7: Growth factor receptor-bound protein 7 | 4.01 | Evidence | |||||
PIK3R2 | GRAP | GRAP: GRB2-related adapter protein | 3.6 | Evidence | |||||
PIK3R2 | SNX3 | N/A | 3.33 | Evidence | |||||
PIK3R2 | OPTC | OPTC, OPT: Opticin precursor | 3.28 | Evidence | |||||
PIK3R2 | PECAM1 | PECAM1: Platelet endothelial cell adhesion molecule precursor | 3.12 | Evidence | |||||
PIK3R2 | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 3.05 | Evidence | |||||
PIK3R2 | BCAN | BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor | 3.02 | Evidence | |||||
PIK3R2 | IL13RA1 | IL13RA1, IL13R, IL13RA: Interleukin-13 receptor alpha-1 chain precursor | 2.84 | Evidence | |||||
PIK3R2 | S100A3 | S100A3, S100E: Protein S100-A3 | 2.40 | Evidence | |||||
PIK3R2 | GABRB1 | GABRB1: Gamma-aminobutyric acid receptor subunit beta-1 precursor | 2.19 | Evidence | |||||
PIK3R2 | BMX | N/A | 2.1 | Evidence | |||||
PIK3R2 | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 2.0 | Evidence | |||||
PIK3R2 | EFNA1 | EFNA1, EPLG1, LERK1, TNFAIP4: Ephrin-A1 precursor | 1.96 | Evidence | |||||
PIK3R2 | CREB1 | CREB1: cAMP response element-binding protein | 1.78 | Evidence | |||||
PIK3R2 | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 1.72 | Evidence | |||||
PIK3R2 | CHN2 | CHN2, ARHGAP3, BCH: Beta-chimaerin | 1.62 | Evidence | |||||
PIK3R2 | SCAP2 | SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 | 1.62 | Evidence | |||||
PIK3R2 | SMAD1 | SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 | 1.53 | Evidence | |||||
PIK3R2 | CDC23 | CDC23: Cell division cycle protein 23 homolog | 1.52 | Evidence | |||||
PIK3R2 | CASP3 | CASP3, CPP32: Caspase-3 precursor | 1.5 | Evidence | |||||
PIK3R2 | NTRK2 | NTRK2, TRKB: BDNF/NT-3 growth factors receptor precursor | 1.32 | Evidence | |||||
PIK3R2 | PTK7 | PTK7, CCK4: Tyrosine-protein kinase-like 7 precursor | 1.32 | Evidence | |||||
PIK3R2 | RPL3 | RPL3, OK/SW-cl.32: 60S ribosomal protein L3 | 1.23 | Evidence | |||||
PIK3R2 | FLT4 | VEGFR3 long form | 1.18 | Evidence | |||||
PIK3R2 | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 1.15 | Evidence | |||||
PIK3R2 | ABL2 | ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 | 1.13 | Evidence | |||||
PIK3R2 | TESK1 | TESK1: Dual specificity testis-specific protein kinase 1 | 1.04 | Evidence |